VANCOUVER, British Columbia, July 02, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CNSX:BLO.CN) (OTCID:BLOZF) (Frankfurt:8CT.GF) (the “Company” or “Cannabix”) developer of marijuana and alcohol breath testing technologies for workplace safety and law enforcement, announces the detection of methamphetamine and amphetamine compounds in human breath samples tested with the Cannabix Marijuana Breath Test (“MBT”). Human breath samples were collected using the Cannabix Breath Collection Unit (“BCU”) (Figure 1) and were analyzed by Omega Laboratories Inc. (“Omega”) utilizing liquid chromatography-mass spectrometry ("LC-MS").
Read more at globenewswire.comThis article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
/Medical%20lab%20microscope%20chemistry%20biology%20test%20by%20Shutter2U%20via%20Adobe%20Stock.jpeg)
/AI%20(artificial%20intelligence)/An%20aerial%20view%20of%20a%20data%20center%20cooling%20system%20by%20Sepia100%20via%20Adobe%20Stock.jpeg)
/Jen-Hsun%20Huan%20NVIDIA's%20Founder%2C%20President%20and%20CEO%20by%20jamesonwu1972%20via%20Shutterstock.jpg)
